NAMs - PONDY
Welcome to
New Approach Methodologies (NAMs) in Pharmacology and Toxicology Testing
Theme: "NAMs In Biomedicine: An Interdisciplinary Perspective of Animal Alternatives"
Sri Balaji Vidyapeeth (SBV), a Deemed-to-be-University accredited with NAAC A++ and recognized by UGC. Mahatma Gandhi Medical Advanced Research Institute (MGMARI) is an autonomous research-based institution dedicated to advancing medical research, encompassing clinical, translational and basic studies. It features state-of-the-art laboratories and Technological resources, supporting innovation and educational opportunities for researchers and students. MGMARI includes MGM Preclinical Research Centre (MGMPRC) which enables compliance with OECD GLP guidelines for toxicology and safety assessments. The Centre provides scalable evaluation of new drugs and treatments using animal models and in vitro systems. Research focuses on drug development, toxicology, pharmacokinetics, and pharmacodynamics, generating critical data to support risk assessment and advance new medical therapies.
The Society for Alternatives to Animal Experiments (SAAE) at the National Centre for Alternatives to Animal Experiments (erstwhile MGDC), Bharathidasan University, Tiruchirappalli, Tamil Nadu, actively promotes humane education system with animal alternatives in education, research and testing towards 3Rs concept. NAMs-PY is a Satellite Program to 7th SAAE-I and 4th ACAAE, Jamia Hamdard, New Delhi, Dec 12-14, 2024.
Registration
Registration end on Nov 30, 2024
Abstract Submission ends on: Nov 24, 2024
Benefits: Certificate, TNMC Credits, Awards
* Your registration confirms only participation in the event. University doesn’t have accommodation facility. Please make your own arrangements.
Conference & Workshops Date
Dec 05 - 07, 2024 (Hybrid Mode)
Program Highlights
In vitro pharmacology and toxicology:
High-throughput screening in Microphysiological Systems
Ex vivo pharmacology and toxicology:
Lab – Organ – Human – on chip
In silico pharmacology and predictive toxicology:
Organs, mutagenicity and toxicogenomics A
In chemico toxicology:
Cheminformatics in hazard risk minimization strategies Emerging regulatory landscapes
About the Conference
New Approach Methodologies (NAMs) represent a paradigm shift in pharmacology and toxicology testing by offering innovative alternatives to traditional animal-based methods. The Origami in Toxicology include advanced in vitro models, such as cell-based assays and lab-organ-human-on-chip systems, which provide more relevant insights into drug effects and chemical interactions by simulating tissues in ex vivo microphysiological systems. NAMs improve the predictive power of drug and chemical safety evaluations in addition to knowing the potential risks and also align with ethical standards, making research and development more efficient and humane. In silico methods, like molecular docking and QSAR models, use computer simulations to predict molecular interactions in organs, mutagenicity toxicogenomics and streamline drug development pipeline. In chemico high-throughput virtual screening and omics technologies enable rapid and comprehensive analysis of compounds, enhancing the accuracy of safety assessments. By focusing on human-derived systems and reducing reliance on animal testing, NAMs not only improve the prediction of drug and chemical safety evaluations but also behold emerging regulatory landscapes to serve public next generation risk and assessment.
Who can attend
The target audience include undergraduate, postgraduate, PhD scholars, faculty, researchers, startup, CRO and industry.
Poster Session and Oral Presentations: We invite abstracts from UG, PG, PhD and faculty for poster and oral presentations. Abstract should not be more than 300 words. Topics can be related to pharmacology and toxicology. Mention whether participating in poster or oral presentation in the registration form. Poster size (3 ft width, 5 ft height). Oral presentation (10 mins; 2 mins Q&A).
Registration Details
